MedTrace Logo

A Study to Assess the Bioavailability of ASP015K

NCT01430078 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2011-09-07

No results posted yet for this study

Summary

The objective of the study is to assess the bioavailability of ASP015K within the gastrointestinal tract.

Conditions

  • Healthy

Interventions

DRUG

ASP015K

oral tablet

DRUG

ASP015K

solution via oral capsule

Sponsors & Collaborators

  • Astellas Pharma Inc

    lead INDUSTRY

Principal Investigators

  • Medical Director · Astellas Pharma Global Development

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01430078 on ClinicalTrials.gov